"The U.S. Food and Drug Administration today expanded the approved use of Xgeva (denosumab) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
GCTB generally occurs in a"...
(Generic versions may still be available.)
Penetrex (enoxacin) is contraindicated in persons with a history of hypersensitivity, tendinitis, or tendon rupture associated with the use of enoxacin or any member of the quinolone group of antimicrobial agents.
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Penetrex Information
Report Problems to the Food and Drug Administration
Find out what women really need.